The 6th Annual Nordic-American
Life Science Conference

CONNECT FOR MORE INFORMATION

Join life science and banking experts, and distinguished partners to learn about advances in oncology, rare diseases, neurology, diagnostic imaging, and many other therapeutic areas.

Insight into the best of Nordic investment opportunities.
Expert insights for corporate and investor communities into the thriving Nordic life science ecosystems.
Participation by institutional investors, prominent public companies, partners, DNB research analysts, bankers, and Back Bay strategists.
Discussion of global drivers and development in Nordic geographies.
Connections to Nordic life science clusters and industry representatives.

WATCH THE 2020 VIDEOS:

View BioPharma, MedTech and Global Markets Day presentations and panel discussions:

Global Markets Day

FOR MORE INFORMATION PLEASE CONNECT WITH US

CONNECT

Celebrating Nordic-American Life Science Investment and Partnering

The Nordic American Life Science (NALS) Conference is a globally recognized conference for leading Nordic biopharma, medtech, and healthtech companies, institutional and private investors, innovation scouts and business developers.

This year, the focus of the conference will be on securing the deal at every stage, the process of licensing, partnering and investment strategies for companies of all sizes.

The conference is held across multiple days, giving global investors the opportunity to connect with high-caliber biopharma, medtech and healthtech companies and leaders in life science development and funding.

For 2021, The Nordic American Life Science Conference will remain virtual. This allows for easy access from the farthest corners of the globe.

Pioneering Cross-Border US-Nordic Investment

Now in our sixth year, The Nordic American Life Science Conference is proud to be the first conference dedicated to cross-border investment from Nordic and North American public and private investors.

Our partners pioneered “boutique by-invitation” format bringing together high-caliber Nordic life science companies with strategic partners and investors.

Our program is a collaboration between life science thought leaders and an extensive network of Nordic life science organizations. With a shared mission of promoting partnership between two robust ecosystems, the NALS Conference is offered at no charge to companies and registrants.

We have rung the closing bell at NASDAQ, NYC, and seen our NALS Companies go on to many successes, including Nordic Nanovector, Oncopeptides, Cerebriu, Ambu, Immedica, Sonoclear, and so many others.

To learn more or to become involved with The Nordic American Life Science Conference, please reach out. We look forward to hearing from you!

See below to learn more about our contributing Nordic alliances.